Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities

scientific article published on 01 June 1982

Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2
P698PubMed publication ID7074555

P2093author name stringF Lejeune
A Morabito
N Cascinelli
S Kirov
U Veronesi
J Adamus
E Caceres
Z Mechl
A Kulakowski
E van Slooten
J Lacour
D C Bandiera
N N Trapeznikov
S Sergeev
R I Wagner
R L Ikonopisov
K Szczygiel
F Claudio
I Rodé
O Brennhovd
V V Javorski
P433issue11
P407language of work or nameEnglishQ1860
P1104number of pages11
P304page(s)2420-2430
P577publication date1982-06-01
P1433published inCancerQ326041
P1476titleDelayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities
P478volume49

Reverse relations

cites work (P2860)
Q52142486A historical perspective on the development of intraoperative lymphatic mapping and selective lymphadenectomy.
Q30275914A retrospective analysis of the role of adjuvant radiotherapy in the treatment of cutaneous melanoma
Q35133268A selective approach to regional lymphatics in melanoma.
Q50524264Advances in melanoma therapy.
Q42011672Age and malignant melanoma: comparison of variables in different age-groups.
Q34120201Biologic and clinical significance of lymphadenectomy
Q43669407Clinical Evaluation of Cutaneous Malignant Melanoma with Histologically Involved Lymph Node Metastases
Q40501956Clinical management of the regional lymph node
Q68306872Clinical stage I melanoma among patients who presented with lesions of Clark levels deep III through V
Q64996630Clinical stage-I malignant melanoma.
Q44414066Combined endoscopic and open inguinal dissection for malignant melanoma
Q50181658Completing the Dissection in Melanoma: Increasing Decision Precision
Q35981868Cure and cosmesis in the management of primary malignant melanoma
Q33705837Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care?
Q36049052Cutaneous melanoma
Q41493111Dermatology-important advances in clinical medicine: surgical treatment of primary malignant melanoma
Q37063136Dilemma of clinically node-negative head and neck melanoma: outcome of "watch and wait" policy, elective lymph node dissection, and sentinel node biopsy--a systematic review
Q71545789Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
Q72342623Elective lymph node dissection (ELND) for malignant melanoma
Q40717524Elective lymph node dissection for melanoma
Q35993059Elective lymph node dissection for melanoma: two perspectives
Q35625961Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck.
Q72871390Follow-up in stage I cutaneous malignant melanoma: an audit
Q43673656Fundamentals of contemporary surgical oncology: biologic principles and the threshold concept govern treatment and outcomes
Q34349420Gamma-probe-guided lymph node localization in malignant melanoma
Q35215733Groin surgery and the sentinel lymph node
Q33712026Historical perspectives and future applications.
Q71991814Ilioinguinal block dissection for malignant melanoma
Q53355519Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.
Q34982566Immunolymphoscintigraphy for metastatic sentinel nodes: test of a model
Q57741285Impact of sentinel lymphadenectomy on survival in a murine model of melanoma
Q36923881Importance of sentinel lymph node biopsy in patients with thin melanoma
Q37521168Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic
Q34677773Intermediate- and high-risk melanoma
Q46947630Intraoperative lymphatic mapping for early-stage melanoma of the head and neck
Q50752731Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma.
Q26750741Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature
Q74012235Judging the therapeutic value of lymph node dissections for melanoma
Q88733680Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials
Q34570034Lymph-node metastases in patients with melanoma: what is the optimum management?
Q36689098Lymphadenectomy promotes tumor growth and cancer cell dissemination in the spontaneous RET mouse model of human uveal melanoma
Q50799598Lymphatic drainage of skin to a sentinel lymph node in a feline model.
Q77366782Lymphatic mapping and selective lymphadenectomy as an alternative to elective lymph node dissection in patients with malignant melanoma
Q50508492Lympho-gammagraphy and study of sentinel node in cutaneous melanoma
Q30310825Lymphoscintigraphy and Sentinel Node Biopsy Accurately Stage Melanoma in Patients Presenting After Wide Local Excision
Q41448755Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers
Q73643261Malignant melanoma
Q71748981Malignant melanoma of the penis
Q36798862Malignant melanoma of the skin
Q71828002Malignant melanoma of the vulva. Report of 89 patients
Q35084330Malignant melanoma: current state of primary and adjuvant treatment
Q40427516Management of Stage I Malignant Melanoma
Q35993091Management of the regional lymph nodes in patients with cutaneous malignant melanoma
Q51515720Melanoma complicating pregnancy.
Q74473991Melanoma of the face: the safety of narrow excision margins
Q33932031Melanoma. A multidisciplinary approach for the general surgeon
Q54374743Metastatic melanoma of the parotid lymph nodes.
Q33846098Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease
Q33696595Nodal radiation therapy for metastatic melanoma
Q40975274Open trials in cutaneous malignant melanoma
Q40631384Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients
Q74784641Preservation of muscle fascia to decrease lymphedema after complete axillary and ilioinguinofemoral lymphadenectomy for melanoma
Q41713870Principles and guidelines for surgeons: management of cutaneous malignant melanoma. European Society of Surgical Oncology Brussels
Q77366773Prognosis in malignant melanoma
Q41520554Prognostic Factors in Malignant Melanoma
Q52568001Prognostic Significance of DNA Aneuploidy in Stage I Cutaneous Melanoma
Q35126553Radiation therapy for malignant melanoma
Q34584757Randomized clinical trials in melanoma
Q72115871Rare sites of melanoma: melanoma of the external ear
Q35545019Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma
Q41317571Recent advances in the care of the patient with malignant melanoma
Q74489477Recent advances in the treatment of patients with malignant melanoma
Q71836662Role of Elective Lymph Node Dissection in Stage I Malignant Melanoma: Evaluation by Matched Pair Analysis
Q74552332Role of elective lymph node dissection in melanoma
Q77667956Role of lymphatic mapping and sentinel node biopsy in the detection of melanoma nodal metastases
Q77165870Selective sentinel node biopsy in melanoma using preoperative lymphoscintigraphy location and intraoperative detection gamma probe
Q35539177Sentinel Lymph Node Biopsy Has No Benefit for Patients with Primary Cutaneous Melanoma Metastatic to a Lymph Node: An Assertion Based on Comprehensive, Critical Analysis
Q64236062Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
Q58092607Sentinel Lymph Node Biopsy: Past and Present Implications for the Management of Cutaneous Melanoma with Nodal Metastasis
Q35576177Sentinel lymph node biopsy for melanoma of the head and neck
Q73543881Sentinel lymph node biopsy in malignant melanoma: the standard of care?
Q35805488Sentinel lymph node biopsy progress in surgical treatment of cancer
Q62711468Sentinel node biopsy and ultrasound scanning in cutaneous melanoma
Q33890196Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute
Q81787038Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study
Q50522349Sentinel node biopsy: a revolution in the surgical management of breast cancer?
Q36616239Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis
Q69786103Should elective lymph node dissection be used for treatment of primary melanoma?
Q41169861Stage II melanoma in the West of Scotland, 1976–1985: Prognostic factors for survival
Q40789228Staging of melanoma
Q33693906State of melanoma: an historic overview of a field in transition
Q37271951State of the science 60th anniversary review: 60 Years of advances in cutaneous melanoma epidemiology, diagnosis, and treatment, as reported in the journal Cancer.
Q37266677Surgery and radiotherapy in the treatment of cutaneous melanoma
Q34964496Surgical approaches to malignant melanoma. Practical guidelines
Q35126561Surgical clinical trials in melanoma
Q38682523Surgical management of malignant melanoma of the trunk and extremities
Q30466404Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients
Q41207360Surgical management of stage I and II melanoma patients: approach to the regional lymph node basin
Q35105675Surgical treatment of malignant melanoma
Q73719908Technique and results of regional hyperthermic cytostatic arm perfusion for malignant melanoma
Q42787369The argument against sentinel node biopsy for malignant melanoma
Q33631121The changing role of surgery in the diagnosis and treatment of cancer
Q33828582The concept of sentinel node localization: how it started
Q70935873The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma
Q33828587The pathologist's role in sentinel lymph node evaluation
Q34584396The role of sentinel lymph node biopsy in the management of melanoma
Q33811544Therapeutic advances in melanoma
Q37347488Therapeutic effect of sentinel lymph node biopsy in melanoma remains an open question
Q39726061Therapy of primary cutaneous melanoma.
Q63977902Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression
Q82150839Time for comprehensive reporting of MSLT-I
Q39801051Treatment of cutaneous melanoma: current approaches and future prospects.
Q36296269Treatment strategy for cutaneous malignant melanoma
Q33752235Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group
Q77376752Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma
Q47578223Vulvar melanoma: is there a role for sentinel lymph node biopsy?
Q82295588[Anatomical location of the primary tumor as a variable to be considered in sentinel node biopsy of cutaneous melanoma]
Q70570700[Axillary recurrence after lymph node excision in malignant melanoma]
Q77900052[Contribution of radioguided detection and selective biopsy of the sentinel lymph node to staging in 100 patients with cutaneous melanoma]
Q72914368[Inguinal recurrence after therapeutic lymphadenectomy in malignant melanoma]
Q73262504[Malignant neoplasms of the penis]
Q81735844[Sentinel node biopsy. What are the facts?]
Q81331234[The role of sentinel lymph node biopsy in the diagnosis and prognosis of malignant melanoma]

Search more.